The coordination of iBET participation in ADDovenom project will be conducted by CEO, Professor Paula Alves, a renowned scientist in the animal cell technology field with more than 250 published research articles in peer -review journals and a special interest in both upstream and downstream process of complex biopharmaceuticals such as viral vectors for gene therapy. Prof Alves has 22+ years of experience in animal cell technology and bioprocess development.